Carey Danis & Lowe | Attorneys at Law
  • Home
  • Our Attorneys
    • About Carey Danis & Lowe
  • Featured Cases
  • Practice Areas
    • Antitrust
    • Class Actions
      • AT&T Cell Phone Bill Cramming
      • AT&T Telephone Bill Cramming
      • Credit Card Payment Protection
    • Defective & Faulty Medical Device Litigation
      • Guidant Defibrillator
      • Hip & Knee Replacement
      • Ob Tape & Slings
      • Transvaginal Mesh
    • Medical Malpractice
    • Personal Injury
      • Truck & Car Accidents
    • Pharmaceutical Litigation
      • Accutane®
      • Actos®
      • Asbestos Mesothelioma
      • Avandia®
      • Celexa®
      • Levaquin®
      • Lexapro®
      • Luvox®
      • Mirena®
      • NuvaRing®
      • Paxil®
      • Pradaxa®
      • Prozac®
      • Symbyax®
      • Topamax®
      • Wellbutrin®
      • Yaz® Yasmin®
      • Zoloft®
    • Product Liability
    • Securities Fraud
    • Unfair & Deceptive Trades
  • Firm News
    • Firm Resume
    • Press Release
    • Testimonials
  • Contact Us
    • via Email
    • via Facebook
    • via LinkedIn
    • via Twitter
    • via RSS
  • Blog
Like Carey Danis & Lowe on FacebookConnect With Carey Danis & Lowe on LinkedInFollow Carey Danis & Lowe on TwitterSubscribe to Carey Danis & Lowe via RSS

  P.  800.721.2519
 Ask a Nurse

small http://grotpaydayloans.com

Home » Predatory Lending • Unfair Deceptive Trades » Barclays Bank Account Protecto ...

Barclays Bank Account Protector Program Class Action

Barclays Bank Account Protector Program Class ActionCarey Danis & Lowe is currently investigating claims that Barclays Bank is engaging in unfair and deceptive trade practices in connection with the sale and administration of their Account Protector program, which is a debt suspension / debt cancellation plan offered to its card members for a fee.

In particular, CD&L is investigating claims that Barclays Bank enrolls card members into their payment protection plan without first determining whether the consumer is qualified to ever receive benefits under the program. The result is that card members are paying fees even though they can never receive benefits.

In addition, the lawyers at CD&L are investigating whether Barclays Bank is enrolling card members into the Account Protector program without their consent or authorization and subsequently charging them a recurring monthly fee.

If you were enrolled into a payment protection plan or program without your consent, please contact us today. penny stock picks

Submit Your Claim

2+3 

    • Tweet
     
     

    If you or a loved one has been injured, submit your claim for a free consultation here or call toll free 800.721.2519



    « Toward The Past: Federal Action Targets Transvaginal (TVM) ‘Mesh’ Surgical Repairs
    Toward The Future: AT&T Wireless Cell Phone Bill Cramming Class Action »



    This artice has been read 910 times.


    Filed under: Predatory Lending, Unfair Deceptive Trades
    Tagged with: , Account Protector, Barclays Bank, payment, program, protection
    Posted by: Scott Godar

     
    • Featured Cases & Current Litigation

      • Vaginal Mesh Litigation
      • Topamax® Birth Defects
      • Lexapro® & Birth Defects
      • Pradaxa® Internal Bleeding
      • Prozac® & Birth Defects
      • Yaz® & Yasmin® Blood Clots
      • Transvaginal Mesh Injury
      • Paxil® & Birth Defects
      • NuvaRing® Blood Clots
      • Mirena® IUD Complications
      • Asbestos Mesothelioma
      • Trucking Accidents & Passenger Vehicle Collision Settlements
    • Recent Posts & News Articles

      • NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey
      • Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award
      • Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy
      • Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer
      • Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
      • Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
      • FDA Approves New Anticoagulation Reversal Agent and Boehringer Ingelheim Updates Pradaxa Label
      • Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award
    Our Offices
    Saint Louis, Missouri
    8235 Forsyth Ste 1100
    St. Louis, MO 63105
    T. 314 725 7700
    F. 314 721 0905
    Godfrey, Illinois
    5512 Godfrey Road
    Godfrey, IL 62035
    T. 618 463 0644
    F. 314 721 0905
    Belleville, Illinois
    5111 W. Main Street
    Belleville, IL 62226
    T. 618 212 6300
    F. 314 721 0905
    Vero Beach, Florida
    612 Beachland Blvd
    Vero Beach, FL 32963
    T. 314 725 7700
    F. 314 721 0905
    © 2013 Carey Danis & Lowe
    reVisioned.by
    Toll Free P. 800-721-2519
    Home • Contact • About